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Abstract
Background: Despite the well documented advantages of hospice care, most terminally ill patients do not reap
the maximum benefit from hospice services, with the majority of them receiving hospice care either prematurely
or delayed. Decision systems to improve the hospice referral process are sorely needed.
Methods: We present a novel theoretical framework that is based on well-established methodologies of
prognostication and decision analysis to assist with the hospice referral process for terminally ill patients. We linked
the SUPPORT statistical model, widely regarded as one of the most accurate models for prognostication of
terminally ill patients, with the recently developed regret based decision curve analysis (regret DCA). We extend the
regret DCA methodology to consider harms associated with the prognostication test as well as harms and effects
of the management strategies. In order to enable patients and physicians in making these complex decisions in
real-time, we developed an easily accessible web-based decision support system available at the point of care.
Results: The web-based decision support system facilitates the hospice referral process in three steps. First, the
patient or surrogate is interviewed to elicit his/her personal preferences regarding the continuation of life-
sustaining treatment vs. palliative care. Then, regret DCA is employed to identify the best strategy for the particular
patient in terms of threshold probability at which he/she is indifferent between continuation of treatment and of
hospice referral. Finally, if necessary, the probabilities of survival and death for the particular patient are computed
based on the SUPPORT prognostication model and contrasted with the patient’s threshold probability. The web-
based design of the CDSS enables patients, physicians, and family members to participate in the decision process
from anywhere internet access is available.
Conclusions: We present a theoretical framework to facilitate the hospice referral process. Further rigorous clinical
evaluation including testing in a prospective randomized controlled trial is required and planned.
Background
Introduction
Hospice services have been proven to provide better
quality of care to dying patients[1-3] by optimizing pain
relief [4,5] and reducing emotional stress [1,6,7].
Furthermore, hospice care is associated with greater
patient-family satisfaction[8], is shown to be cost effec-
tive[9,10], and most importantly, it has been attributed
with increased survival in some patients [11]. Despite
these well documented advantages, many terminally ill
patients do not reap maximum benefits from hospice
care. The fundamental reason for this is related to the
less than optimal and frequently poorly timed refer-
ral of terminally ill patients to hospice [1,12]. As a
result, many patients die within a few days of referral,
or live many years after the referral was made [13].
According to Medicare regulations, a person should be
referred to hospice if his/her “life expectancy (LE) is 6
months or less” [1,14]. Hence, the problem of meaning-
ful referrals relates to the accurate estimation (prog-
nosis) of death within approximately 6 months after
evaluation for hospice care. However, statistical models
designed to assist physicians in predicting life
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failed to improve the quality of care at the end of life
[17-21].
One such statistical model is SUPPORT (Study to
Understand Prognoses and Preferences for Outcomes
and Risks of Treatments), designed to calculate the
probability of survival over a period of 180 days [22,23].
Although the SUPPORT model has been well validated
[17,22] for prognostication of LE in terminally ill
patients, a controlled trial of SUPPORT failed to
demonstrate any impact on the overall quality of care
for these patients [17,20]. We postulate that this lack of
impact may be due to the fact that SUPPORT results,
were not linked to any decision methodology that would
translate the probability of survival to a hospice referral
recommendation. Therefore, the full potential of the
model’s prognostication power remained unexploited.
In this work, we link the SUPPORT prognostication
model with the recently developed decision methodology
regret DCA [24] to facilitate the hospice referral process.
Regret DCA relies on regret theory and decision curve ana-
lysis [25] to recommend the optimal management strategy
for a patient, accounting for the personal attitudes and
values of the particular patient or his/her surrogate.
Furthermore, we extend regret DCA to incorporate
harms and effects of treatment as well as harms asso-
ciated with the prognostication test to the decision
model. The presented methodology is integrated into a
comprehensive clinical decision support system devel-
oped to facilitate the hospice referral process.
Methods
Dataset
In our analysis, we utilized the entire SUPPORT dataset,
both development and validation cohorts. The dataset is
presented in detail elsewhere [22]. Medical records of
8,329 seriously ill hospitalized adults are included.
Support model
SUPPORT is a multivariable model designed to estimate
probability of survival for seriously ill hospitalized
patients over a period of the subsequent 180 days. The
model variables include the patient’s medical condition
compatible with one of eight major diagnostic groupings
(Acute Respiratory Failure, Multiple Organ System Fail-
ure, Chronic Obstructive Pulmonary Disease, Congestive
Heart Failure, Hepatic Cirrhosis, Neurological Coma,
Lung or Colon Cancer), the patient’s current age, num-
ber of days in the hospital before study entry, neurologic
status, and 11 physiologic measures recorded on day 3
after study entry [22].
The SUPPORT implementation for the estimation of
survival probability is detailed in the appendix. Due to
the nature of the hospice referral problem we also
express the survival probability in terms of mortality.
We can convert the estimated survival probability (SP)
(equation A2) to probability of death within 180 days
(denoted here as p) using the equation:
p =1− SP =1− P{T ≥ t|disease group = i} (1)
where SP is the survival probability computed by SUP-
PORT, i Î [1,8] the patient’s disease group, T is the sur-
vival time in days, and t is an arbitrary time (typically
expressed in days e.g. t Î [1,180]).
In terms of accuracy, the SUPPORT model has an
area under the receiver-operating characteristics curve
(ROC) for prediction of surviving 180 days of 0.79 in
the phase I development cohort and 0.78 in the phase II
validation cohort [22].
Decision model
Figure 1 depicts the decision tree summarizing the pro-
cess of hospice referral. The four outcomes and their
corresponding utilities (U) shown are:
Figure 1 Decision tree for hospice referral. In this figure, p is the probability that a patient’s LE is less than or equal to 6 months; 1-p is the
probability that a patient’s LE is greater than 6 months; Ui: are the utilities associated with each outcome; Rgi is the regret associated with each
outcome.
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Page 2 of 131. U1: Refer the patient to hospice and the patient’s
LE is less than or equal to 6 months (Hosp|LE ≤ 6).
2. U2: Refer the patient to hospice and the patient’s
LE is greater than 6 months (Hosp|LE > 6).
3. U3: Continue treating the patient and the patient’s
LE is less than or equal to 6 months (Rx|LE ≤ 6).
4. U4: Continue treating the patient and the patient’s
LE is greater than 6 months (Rx|LE > 6).
p is the probability associated with the presence of an
event (e.g. patient’sL E≤ 6 months) as predicted by the
SUPPORT model, 1 - p is the probability associated
with the absence of the same event (e.g. patient’sL E>6
months).
As with any decision, one may come to realize that, in
retrospect, an alternative decision would have been pre-
ferable. This knowledge may bring a sense of loss or
regret [26-32]. In this paper, we use this sense of regret
to determine the preferences of the decision maker
towards alternative management strategies. Specifically,
we employ regret theory to estimate the threshold prob-
ability, Pt, at which the decision maker (patient, physi-
cian, or family member) is indifferent between
continuation of treatment vs. hospice referral. Based on
the concept of threshold probability, the patient should
be referred to hospice if his/her probability of death is
greater than or equal to Pt(e.g. p ≥ Pt), and he/she
should continue receiving curative treatment otherwise
(p <Pt).
The threshold probability is derived as [24]:
Pt =
1
1+
U1−U3
U4−U2
(2)
In (2) U1-U3 is associated with regret of omission (e.g.
the patient was not referred to hospice, instead he/she
continued receiving unnecessary treatment) and U4-U2
with regret of commission (e.g. the patient was unneces-
sary referred to hospice instead of continue receiving
life-sustaining treatment) [24].
To elicit the decision maker’s regret, and therefore
threshold probability, we utilize the DVAS (Dual Visual
Analogue Scale) method [24]. One visual analogue scale
is used to capture the regret associated with failing to
refer the patient to hospice (e.g. continue unnecessary
treatment) and the second scale to measure the regret
associated with unnecessary hospice referral (e.g. failing
to provide life-sustaining treatment) (Figure 2).
Elicitation of threshold probability can be achieved
through a set of questions such as:
1. On the scale 0 to 100, where 0 indicates no regret
and 100 indicates the maximum regret you could
feel, how would you weigh the level of your regret if
you were not referred to hospice but instead you con-
tinued receiving unnecessary treatment? That is, how
much would you regret if you did not reap the bene-
fits of hospice care? *Note that this value corre-
sponds to U1 -U 3.
2. On the scale 0 to 100, where 0 indicates no regret
and 100 indicates the maximum regret you could
feel, how would you weigh the level of your regret, if
you were referred to hospice instead of continue
receiving necessary life-sustaining treatment? That is,
how much would you regret if you sustained harms
from hospice care? *Note that this value corresponds
to U4 -U 2.
For example, suppose that the patient - who is aware
of his/her terminal condition- answers 50 and 25 to the
questions 1 and 2 respectively. This means that the
p a t i e n tc o n s i d e r s5 0 / 2 5=2t i m e sw o r s en o tt ob e
referred to hospice when necessary than receiving an
unnecessary hospice referral. The threshold probability
for this patient is (equation 2)
pt =
1
1+
U1−U3
U4−U2
=
1
1+50
25
= 0.33 or 33% .
Regret DCA and extensions
The clinical problem we face in the situation of hospice
referral is how to use reasonably accurate predictions of
death, p, coupled with the patient’s preferences (as
expressed in terms of threshold probability, Pt)t oa r r i v e
at the optimal decision for a specific individual. The
problem is decomposed into three strategies: (1) act
based on the prediction model (SUPPORT) (e.g. refer to
hospice if p ≥ Pt and continue treating otherwise), (2)
Figure 2 DVAS (Dual Visual Analogue Scales).T h eD V A Sa r e
used for the elicitation of the decision maker’s threshold probability.
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Page 3 of 13refer all patients to hospice, and (3) continue current
treatment for all patients (i.e. refer no patients to
hospice).
Each of these strategies may inflict physiological and/
or psychological damages to the patient. Specifically, a
patient may suffer harms due to a treatment strategy (e.
g. adverse effects) or harms due to the prognostication
test (e.g. a test requiring invasive procedure). We
express these harms as loss in utility associated with
actions we may undertake. To that end, we define HRx,
HHosp and Hte as the utility losses due to harms of the
treatment, hospice, and prognostic test, respectively.
Figure 3 presents the decision tree describing the
overall hospice referral problem. p = P(D +) is the prob-
ability that the patient’sL Ei sl e s st h a no re q u a lt o6
months as estimated by the prediction model (SUP-
PORT);1 - p = P(D -) is the probability that the patient’s
LE is greater than 6 months, and Ui, i Î [1,4], are the
utilities corresponding to each of the decision model
outcomes (detailed in the previous section). The vari-
ables Hosp and Rx correspond to referring a patient to
hospice and continuing current curative treatment,
respectively. Rg, is the regret associated with an action,
e.g. Rg(Hosp, D-) is the regret one may feel if the patient
was referred to hospice when his/her LE was greater
than 6 months. Finally, te designates that the patient
received a prognostication test.
Considering the decision tree in Figure 3 we can com-
pute the expected regret associated with each decision
in terms of the utilities of each possible outcome as fol-
lows (detailed derivation is presented in the Appendix):
ERg[Hosp]=( 1− p) ∗ (1 − RRRHosp) ∗
Pt
1−Pt (3)
ERg[Rx]=p ∗ (1 − RRRRx) (4)
ERg[SUPPORT]=

1 − RRRHosp ∗ (#TP/n + #FP/n)
−RRRRx ∗ (#FN/n + #TN/n)

∗
Hte
U1 − U3 + HRx − HHosp
+(1 − RRRHosp) ∗
#FP
n
∗
Pt
1 − Pt
+(1 − RRRRx) ∗
#FN
n
(5)
In addition to harms, equations 3, 4 and 5 incorporate
the effects of treatment and hospice care using measures
of Relative Risk Reduction: and RRRRx RRRHosp respec-
tively. The values for these measures are treatment spe-
cific and can be acquired from the literature. We have
incorporated hospice effects because a recent study [11]
has shown that early palliative care for patients with
metastatic non-small cell lung cancer could increase
survival. The variables TP, FP, FN, TN are related to the
prognostic capability of the SUPPORT model (see
appendix for detailed derivation) [24].
Since the regret of omission and regret of commission
have been generalized to include effects and harms
related to management strategies and testing, the func-
tion of threshold probability (equation 2) becomes:
Pt =
1
1+
U1−U3+HRx−HHosp
U4−U2−HRx−HHosp
(6)
Where U1 - U3 + HRx -HHosp corresponds to the regret
associated with not referring the patient to hospice
when necessary, and U4 - U2 - HRx - HHosp corresponds
to the regret associated with unnecessary hospice
referral.
Choosing the optimal strategy
The optimal strategy is selected as the one which will
bring the least amount of regret. The regret DCA algo-
rithm expresses the regret associated with each strategy
in terms of threshold probability and is implemented as
follows [24]:
1. Select a value for threshold probability.
2. Assuming that patients should be referred to hos-
pice if p ≥ Pt and should continue current treatment
otherwise, compute #TP and #FP for the prediction
model.
3. Calculate the ERg(SUPPORT)using equation 5.
Figure 3 Decision tree describing the overall hospice referral
process. In this figure p = P (D +): probability the patient’sL Ei s
less than or equal to 6 months; 1 - p = P (D -): probability the
patient’s LE is greater than 6 months; Ui,iÎ [1,4]: the utilities
corresponding to each of the decision model outcomes; Hosp:
hospice referral; Rx treatment continuation; Rg: regret associated
with an action; HRx : utility losses due to harms of treatment; HHosp:
utility losses due to harms of hospice; Hte: utility losses due to
harms of the prognostic test (SUPPORT).
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Page 4 of 134. Calculate ERg(Rx) using equation 4.
5. Compute the ERg(Hosp)using equation 3.
6. Repeat steps 1 - 6 for a range of threshold
probabilities.
7. Graph each expected regret function calculated in
steps 3-5 against each threshold probability.
At each threshold probability, the action with the low-
est value of expected regret corresponds to the most
desired action. For example, in Figure 4, at a threshold
probability equal to 10% (e.g. the patient considers 9
times worse not to be referred to hospice when necessary
than to receive an unnecessary hospice referral), the opti-
mal strategy is to refer the patient to hospice.
Figures 5, 6 and 7 depict the regret associated with
alternative decision strategies as they relate to different
values of hospice effectiveness (Figure 5), treatment
effectiveness (Figure 6), and harms due to the prognosti-
cation test (Figure 7). As expected, when the harms due
to the prognostication test are increased, then the area
of threshold probability at which the prognostication
model is the optimal decision is reduced (Figure 5).
Even though, it is not expected that the SUPPORT
model will actually create harms, at least physiological,
to the patient, this is not always the case for other diag-
nostic tests that may be more invasive (e.g. screening
for prostate cancer).
As can be seen from Figures 5, 6 and 7 the optimal
decision is derived by the SUPPORT model for a rather
wide range of threshold probabilities. Therefore, it
appears that the SUPPORT model is the superior
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Figure 4 Decision curves for hospice referral.I nt h i sf i g u r e ,
RRRHosp = 0, RRRRx =0 ,H Rx =H Hosp =H te = 0. At threshold
probability equal to 10%, the optimal decision is refer the patient to
hospice; at 40% the optimal decision is to use the SUPPORT model.
Figure 5 Decision curves as a function of RRRRX.I nt h i sf i g u r e ,
RRRHosp = 0, RRRRx = 2 to 8%, HRx =H Hosp =H te = 0. As the effect
of treatment increases, the regret associated with treating all
patients and with the SUPPORT model slightly decreases. The
strategy of using the SUPPORT model to refer a patient to hospice
is the action with the least amount of regret for the wider range of
threshold probabilities.
Figure 6 Decision curves as a function of RRRHosp. In this figure,
RRRHosp = 2% to 8%, RRRRx =0 ,H Rx =H Hosp =H te = 0. As the effect
of hospice care increases, the regret associated with hospice and
with the SUPPORT model slightly decreases. As previously, the
strategy of using the SUPPORT model to refer a patient to hospice
is the action with the least amount of regret for a wide range of
threshold probabilities.
Figure 7 Decision curves as a function of Hte.I nt h i sf i g u r e ,
RRRHosp = 0, RRRRx =0 ,H Rx =H Hosp = 0 and Hte = 0% and 10%. As
the harms associated to the prediction test increase, so does the
expected regret of utilizing the SUPPORT model for hospice referral.
Increasing the harms due to treatment or due to hospice care does
not have an effect on the decision curves.
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Page 5 of 13strategy for the vast majority of decision makers, regard-
less the effects of the alternative management strategies.
However, since the threshold probability expresses the
personal preferences of a particular decision maker, it is
not unusual for specific patients to have smaller or
greater threshold probability values than the majority of
decision makers. This is the power of the proposed
methodology, which allows for decision making at the
individual level. For example, if the decision maker pre-
sents a threshold probability greater than ≈92%, the
optimal decision would be to continue life-sustaining
treatment even if it is deemed not to be effective(Figure
4). Similarly, for small values of threshold probability,
the desired action would be to refer the patient to
hospice.
Decision Support System
As our theoretical discussion highlighted, decisions
about life and death are complex and difficult at both
the emotional and cognitive level. Therefore, it is not
surprising that the SUPPORT model originally failed to
improve the quality of care for terminally ill patients
despite its reasonable accuracy in prediction of probabil-
ity of survival [17,20]. Any attempt to focus on a single
dimension of the complex hospice referral process is
not likely to succeed. An accurate prognostic model is
only the first step. Having the apparatus to take into
account trade-offs associated with the hospice referral
decision while taking into consideration the patients’
preferences represent further necessary steps to improve
the care of terminally ill patients. In addition, we
hypothesize that the SUPPORT intervention failed
b e c a u s ei tw a sn o ta v a i l a b l ea tt h ep o i n to fc a r ei nr e a l
time. This is because the most desired outcomes are
best achieved when decision-making occurs in real-time,
at the point of care [33,34].
To facilitate the decision making process for the hos-
pice referral at bedside, we propose a web-based clinical
decision support system (CDSS) that computes the
probabilities of survival and death for individual patients
using the SUPPORT model, elicits personal preferences
from patients and/or physicians, and utilizes regret DCA
to suggest the optimal decision for a particular patient.
Features
Access
Our goal is to develop a CDSS that can be accessed by
everyone and from anywhere regardless the operating
system one uses. At the same time, it is desirable to
develop a system that can eventually be integrated with
various healthcare providers’ electronic medical records
(EMR). We concluded that a web-based implementation
would fulfil such requirements.
Data storage
The CDSS performs the required computations without
retaining or transmitting sensitive and identifiable
information.
Results
In this section we present a prototype of the CDSS,
developed to demonstrate the applicability of our theo-
retical framework for hospice referral. Each subsection
describes the results of the methods shown in the pre-
vious section in conjunction with the description of the
corresponding module. Figure 8 depicts the logical dia-
gram that outlines the operation of the CDSS. Briefly,
the operation begins by interviewing the patient or sur-
rogate to elicit his/her threshold probability. Based on
the value of threshold probability equation, the optimal
strategy for the particular patient is derived (e.g. refer to
hospice, continue treatment, or use of prediction
model). If the optimal strategy is to follow the
Figure 8 Block diagram outlining the operation of the DSS.
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Page 6 of 13prediction model (SUPPORT), then using the equations
A1, A2 and 1, the probabilities of survival and death are
computed for the particular patient. The probability of
death is then contrasted with the patient’s threshold
probability and the optimal decision is derived (refer to
hospice, or continue treatment). At each step described,
the patient selects the level of information he/she wishes
to be exposed to. For example, the patient may not wish
to know his/her threshold probability or probability of
death. Instead he/she wishes to know only the optimal
decision regarding his/her condition.
General implementation details
The proposed CDSS is a web-based application residing
on the USF Health servers. The web address is http://
health.usf.edu/research/ebm/decisionaids.htm. It has
been developed based on the Adobe
® ColdFusion
®
application technology and the interface has been
designed using html and JavaScript programming lan-
guages. The hardware and software requirements from
the user’s point of view are modest. The system runs on
any contemporary computer with net browsing capabil-
ities. However, at this stage the CDSS is not optimized
for use with handheld devices. The CDSS consists of 3
different modules as described below.
Elicitation of threshold probability module
The threshold elicitation module consists of the dual
visual analogue scales, used to weigh the patient’sr e g r e t
in the case of wrong decisions. Each scale has 100
points where 0 corresponds to no regret and 100 to
maximum regret. Depending on the role of the decision
maker (e.g. patient/surrogate or physician) two different
sets of questions are displayed. These questions are
designed to capture the regret of omission and the
regret of commission. For the remainder of this paper,
we assume that the decision maker is the patient. As in
pain scales [35], each visual analogue scale uses facial
expressions to graphically represent variations in regret
(Figure 9). A summary of the decision maker’sp r e f e r -
ences is presented for final verification. The threshold
probability for the particular patient is derived using
equation 2, however is not displayed until the decision
maker requests it.
Decision module
The decision module utilizes the decision maker’s
threshold probability and the regret DCA methodology
to derive the optimal decision. For example, the prefer-
ences of the patient depicted in Figure 9, correspond to
a threshold probability equal to 29%. From Figure 4 the
Figure 9 Elicitation of threshold probability. The user (patient/surrogate/physician) weighs the two alternative management strategies in
terms of regret.
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Page 7 of 13s t r a t e g yt h a tw i l lb r i n gt h el e a s ta m o u n to fr e g r e ti st o
use the prognostication model (SUPPORT) for the hos-
pice referral recommendation. In this case, the decision
module initiates the SUPPORT module.
SUPPORT module
If the optimal strategy derived by the decision module is
to utilize the prognostication model, the SUPPORT
module is enabled. This module (Figure 10) is used to
compute the probability of death for the particular
patient based on the SUPPORT prognostication model.
Currently, the user inserts all required information to
the CDSS. In the future, this information will be cap-
tured automatically from the health care provider’s elec-
tronic medical records system. Data validation
restrictions have been imposed to protect the integrity
of the collected data.
Once the values of all available variables have been
inserted in the corresponding cells, the patient’sl i f e
expectancy and probabilities of survival and death are
computed. The decision module is employed again to
display the optimal recommendation.
Decision justification module
The decision justification module explains in detail and
at the user’s request the reasons that led to a particular
recommendation (Figure 11). It contains information
regarding the decision maker’s threshold probability, the
optimal strategy associated with the threshold probabil-
i t ya n dt h ep a t i e n t ’s probability of death (if applicable).
Since people often misinterpret probabilities [36], we
complement the results presented in terms of probabil-
ities using frequency format (Figure 11). The latter for-
mat is currently considered the best way to represent
favorable and unfavorable facts regarding medical inter-
ventions [37]. The justification module is highly techni-
cal and should only be reviewed by decision makers
who wish to know more about their or their patient’s
condition.
Case Study
Figure 12 summarizes the decision process for a patient
whose information is simulated in Figures 10, 11 and
12. The probability of death and the threshold probabil-
ity of this patient have been computed as 85% and 29%
respectively. At a 29% threshold probability, the optimal
strategy is to use the prediction model for hospice refer-
ral (Figure 4). Therefore, since p >Pt the patient should
be referred to hospice. For completeness, all possible
decision routes are depicted in Figure 12. The route cor-
responding to the specific simulated patient is shown
using bold arrows.
Figure 10 SUPPORT user interface. The user enters all information regarding the particular patient to compute the probability of death and
survival within the next 6 months. LE results are presented to the patient through the decision justification module after the patient’s request.
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In this article we describe both the theory and applica-
tion behind a hospice referral clinical decision support
system. To the best of our knowledge, this is the first
CDSS that integrates two well established methodolo-
gies, one for prognostication (SUPPORT) and the other
for decision making (regret DCA), to assist with the hos-
pice referral decision-making process.
The recently developed regret DCA incorporates the
decision maker’s preferences towards alternative man-
agement strategies from the perspective of regret theory
in terms of threshold probability. Such an approach pro-
motes personalized patient care. We anticipate that the
regret-based approach is more appropriate for the hos-
pice referral process than other preference elicitation
techniques, due to the nature of the problem where
there are really no optimal options available- the opti-
mal decision can be only considered as the one with the
least regret.
Modern cognitive theories increasingly focus on the so
called dual-processing theory in which both intuition
(system 1) and analytical, deliberative process (system 2)
are important for balancing risks and benefits in the
decision-making process [38]. We believe that rational
decision-making should take into account both formal
principles of rationality and human intuition about good
decisions[24,39,40]. One way to accomplish this is to
use regret, a cognitive emotion, to serve as the link
between systems 1 and 2 [24]. By taking into account
the consequences of our actions as well as the circum-
stances under which we can live with our mistakes we
anticipate that the goal of reconciling the formal
Figure 12 Block diagram summarizing the decision process. The bold route corresponds to the patient simulated in figures 10, 11 and 12.
Figure 11 Justification of the hospice referral recommendation. The particular patient depicted has 29% threshold probability at which the
optimal strategy is derived by the SUPPORT model. The patient has 85% probability of death in the next 180 days. Therefore, the optimal
decision is to be referred to hopsice.
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Page 9 of 13principles of rationality and human intuitions about
good decisions can be met [24,29,39,40]. This is particu-
larly true in the situation of terminally ill patients.
Our web-based CDSS reflects modern cognitive the-
ories to facilitate integration of the decision-making
ingredients necessary for hospice referral decisions. The
CDSS encapsulates all required information for the hos-
pice referral process into a flexible software that can be
used at bedside. Obviously, hospice referral decisions
are complex and must be exercised with full compassion
and deliberation. We advise against the use of our sys-
tem as an automatic decision making tool that by-passes
important personal interactions between the patient and
his/her physician. It is important to stress that the elici-
tation of the threshold probability as described herein
reflects the belief (also captured in recent legislation
[41]) that patients and their families want to be told the
“truth” about the patients’ terminal sickness [22,41,42]
and that physicians have ethical obligations to share this
information with patients and their families [41,42]. Our
system should be understood as an aid to facilitate deci-
sions in terminal phases of patient lives.
Our approach has limitations as well. The main lim-
itation of the proposed system remains the complexity
of the SUPPORT model. Currently, the system still
requires manual entry of data. In addition, failure to
enter all data can jeopardize the accuracy of prediction
and therefore, the decision process. To cope with this
limitation, we plan to integrate our system into various
health providers’ EMRs. Based on each EMR, specifically
designed queries will be used to retrieve lab values and
patient demographics to be fed automatically into our
system; a process that will reduce the amount of missing
values and input errors.
The second limitation of the proposed system is that
empirical data are not available to assess how the system
actually works in practice. While we plan to undertake
empirical testing of the system described here, we
believe that a strong theoretical underpinning will
enable better hospice referral decisions even in the cur-
rent form. This is because our system will essentially
operationalize the decision-making process, which is
supposed to occur in every day practice. Nevertheless,
we need to firstly, identify the system’s feasibility in real
life settings and ultimately, if it appears to be usable and
assessed favourably by all those involved in the hospice-
referral decision-making process, to test it in rando-
mized controlled trials against traditional care.
Our future plans include both empirical testing and
implementation of multiple additional prognostication
models which will be used in parallel to assess optimal
decisions regarding hospice referral and take advantage
of the regret DCA methodology. We anticipate that for
a different range of threshold probabilities these models
may perform better than the SUPPORT model. Further-
more, our intent is to develop a separate version of our
CDSS optimized for mobile devices.
Conclusions
In this work we have presented the theoretical frame-
work, accompanied by the associated CDSS, to facilitate
end of life care decisions. Our work combines the prog-
nostication power of the SUPPORT model, the simpli-
city of the DVAS methodology in eliciting people’s
preferences and the effectiveness of regret DCA at eval-
uating alternative management strategies to resolve the
dilemma of choosing traditional vs. palliative care for
patients at terminal stages. A clinical evaluation of the
CDSS is planned.
Appendix
Support implementation
SUPPORT is implemented in two steps. First, the SUP-
PORT physiology score is computed based on equation
A1 [22].
SPS = 259.9{ARF/MOSF} + 263.4{COPD/CHF}
+24 1.4{Cirrhosis/Coma}
+28 1.5{Lung/ColonCancer}
−0.06174min(PaO2/FiO2,225)
−0.6316min(MeanBP,60)
+1.0205WBC − 0.3676(WBC − 8)+
−0.5631(WBC − 11) + + 0.2691min(Alb,4.6)
+0.23 12Aresp − 2.362Temp + 1.326(Temp − 36.6)+
+2.473(Temp − 38.3)+ − 1.579 × 10−−
1HR
+9.770 × 10−5(HR − 55)
3
+ − 2.189 × 10−4(HR − 80)3
+
+1.5 18× 10−4(HR − 110)3
+
−3.062 × 10−5(HR − 149)3
+ + 0.9763Bil
−0.7481(Bil − 7)+ − 6.8761Cr
+11.6058(Cr − 0.600)
3
+ − 21.8413(Cr − 1.000)
3
+
+10.3574(Cr − 1.500)3
+ − 0.1219(Cr − 5.399)3
+
− 0.6167096Na + 0.0021118(Na − 128)
3
+
−0.0036730(Na − 135)3
+ + 0.0006126(Na − 139)
3
+
+0.0009486(Na − 148)3
+
−6.278{ COPD/CHF}× min(Alb,4.6)
−11.45{ Lung/ColonCancer}× min(Alb,4.6)
+{ARF/MOSF}[−2.3549WBC
+2.7494(WBC − 8)+ − 0.4638(WBC − 11) +]
(A1)
Table 1 Values of Survival (S) as described in equation
A2 for different disease types and varying survival times
tS ARF/MOSF SCOPD/CHP/Cirrhosis SComa SCancer
0 0.994 0.998 0.993 0.993
30 0.691 0.889 0.630 0.578
60 0.601 0.837 0.609 0.407
90 0.562 0.800 0.581 0.264
120 0.532 0.772 0.569 0.190
150 0.508 0.751 0.551 0.135
177 0.493 0.733 0.545 0.108
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Page 10 of 13where:Alb: albumin; Aresp: APACHE III respiration
score; Bil: bilirubin; Cr: Creatinine; Na:s o d i u m ;PaO2:
partial pressure oxygen in arterial blood; MeanBP: mean
arterial blood pressure; WBC: white blood cell count in
thousands; Temp: temperature in Celsius; HR: heart rate
per minute; ARF: Acute respiratory failure; MOSF:M u l -
tiple organ failure; Cirrhosis: Cirrhosis; Coma:C o m a ;
Lung:L u n gc a n c e r ;ColonCancer: Colon cancer; COPD:
Chronic obstructive pulmonary disease; CHF: Congestive
heart failure. Also:
{disease group} =

1, if patient in the disease group
0, otherwise
(x)+ =

x,i f x > 0
0, otherwise
WBC =9 ,i fWBC <9a n d{ disease group } ≠ ARF
/MOSF
WBC = 40, if WBC >4 0
Cr = 15, if Cr >15
The second step in implementing the SUPPORT
model is to calculate the probability of survival for the
individual patient based on equation A2 [22].
P{T ≥ t|disease group = i} = Si(t)e
Xˆ b (A2)
w h e r eT :s u r v i v a lt i m ei nd a y s ;t :a r b i t r a r yt i m e ;S
described in Table 1[22] and
Xˆ b = −3.652 + 0.8356{ CHF} + 0.9257{ Cirrhosis}
+0.6287{ LungCancer}± 1.1803{ MOSFw/Malig}
+0.01434Scoma ± 0.01935Age +0 . 2 4 1 3 Cancer
−1.863

Hday +3 . 4
−1
+0 . 0 8 1 2 1 SPS
+Age[0.015261{ COPD/CHF/Cirrhosis}
+0.009047{ Coma}− 0.008294{ Cancer} ]
+Age[−0.012498{ CHF}− 0.004578{ Cirrhosis}
−0.001435{ LungCancer}
−0.013891{ MOSFw/Malig}
where Scoma: SUPPORT coma score (0-100);
MOSFw/Malig: Multiple organ failure with malignancies;
Hday: day in hospital when qualified for study; Cancer:
Cancer by comorbidity or primary disease category (0 =
no; 1 = present; 2 = metastatic) [22].
Derivation of the Expected Regret functions
As outlined in the Introduction, seriously and terminally
ill patients may reap a number of benefits by the hos-
pice program. Nevertheless, after enrollment into hos-
pice, the patient (or the family, or the physician) may
feel that this was a wrong decision, and subsequently
may regret it. Similarly, the patient may feel regret for
the treatment that he/she continues to receive because
it is unnecessary, inappropriate, and/or harmful. Figure
3 represents our hospice decision tree in terms of regret
from which we can compute the expected values of
regret associated with each strategy as follows:
ERg[Hosp]=
(1 − p) ∗ (U4 − U2 − HRx − HHosp)
(A3)
ERg[Rx]=p ∗ (U1 − U3 + HRx − HHosp) (A4)
ERg[SUPPORT]=p ∗ TP ∗ Hte
+(1− p) ∗ FP
∗(U4 − U2 − (HRx − HHosp)+Hte)
+p ∗ FN ∗ (U1 − U3 +( HRx − HHosp)+Hte)
+(1 − p) ∗ TN ∗ Hte
(A5)
The variables TP, FP, TN, FN are related to the prob-
abilities P (p ≥ Pt ∩ D +), P (p ≥ Pt ∩ D -), P (p <Pt ∩ D
-) and P (p <Pt ∩ D +) respectively, and are estimated as
follows:
￿ P (p ≥ Pt ∩ D +) ≈ the number of patients who will
die within 6 months and for whom the prognostic
probability is greater than or equal to Pt (with #TP
= number of patients with true positive results,
P(p ≥ Pt ∩ D +) ≈ #TP
n ,w h e r en is the total number
of patients in the study).
￿ P (p ≥ Pt ∩ D -) ≈the number of patients who will
survive for longer than 6 months and for whom the
prognostic probability is greater than or equal to Pt
(with #FP = number of patients with false positive
results, P(p ≥ Pt ∩ D−) ≈ #FP
n ).
￿ P (p <Pt ∩ D +) ≈the number of patients who will
die within 6 months and for whom the prognostic
probability is less than Pt (with #FN = number of
patients with false negative results,
P(p < Pt ∩ D+) ≈ #FN
n ).
￿ P (p <Pt ∩ D -) ≈the number of patients who will
survive for longer than 6 months and for whom the
prognostic probability is less than Pt (with #TN =
number of patients with true negative results,
P(p < Pt ∩ D−) ≈ #TN
n ).
To incorporate the effects of alternative treatments (e.
g. treatment and hospice care) in equations A3-A5 we
use the Relative Risk Reduction reported in literature for
each strategy as follows:
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Page 11 of 13ERg[Hosp]=( 1− p) ∗ (1 − RRRHosp)
∗ (U4 − U2 − HRx − HHosp)
(A6)
ERg[Rx]=p ∗ (1 − RRRRx)
∗ (U1 − U3 + HRx − HHosp)
(A7)
ERg[SUPPORT]=
p ∗ (1 − RRRHosp) ∗ TP ∗ Hte
+(1 − p) ∗ (1 − RRRHosp) ∗ FP
∗(U4 − U2 − (HRx − HHosp)+Hte)
+p ∗ (1 − RRRRx) ∗ FN
∗(U1 − U3 +( HRx − HHospe)+Hte)
+(1 − p) ∗ (1 − RRRRx) ∗ TN ∗ Hte
(A8)
Since TP + FN = 1 and FP + TN = 1, we have:
p ∗ TP +( 1− p) ∗ FP + p ∗ FN
+(1 − p) ∗ TN = p +( 1− p)=1
Therefore, equation A8 becomes:
ERg[SUPPORT]=
(1 − p ∗ RRRHosp ∗ TP − (1 − p) ∗ RRRHosp ∗ FP
−p ∗ RRRRx ∗ FN − (1 − p) ∗ RRRRx ∗ TN) ∗ Hte
+(1 − p) ∗ (1 − RRRHosp) ∗ FP
∗

U4 − U2 − (HRx − HHosp)

+p ∗ (1 − RRRRx) ∗ FN
∗

U1 − U3 +( HRx − HHosp)

(A9)
Scaling the equations A3, A4 and A9 with the quantity
(U1 - U3 + HRx - HHosp) and replacing the expression
U4−U2−(HRx−HHosp)
U1−U3+HRx−HHosp with
Pt
1−Pt, we derive the final equations
for the expected regret (equations 3, 4, and 5).
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